Publications by authors named "Nicholas DeMartinis"

Claim this Profile
I
INTERACT: a randomized phase 2 study of the DAAO inhibitor luvadaxistat in adults with schizophrenia.
Venkatesha Murthy, Elizabeth Hanson, Nicholas DeMartinis, Mahnaz Asgharnejad, Cheng Dong

Schizophr Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a randomized double-blind study evaluating luvadaxistat in adults with Friedreich ataxia.
Hao Wang, Jonathan Norton, Lin Xu, Nicholas DeMartinis, Rohini Sen

Ann Clin Transl Neurol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity.
Rita Balice-Gordon, Garry D Honey, Christopher Chatham, Estibaliz Arce, Sridhar Duvvuri, Nicholas DeMartinis

Int J Neuropsychopharmacol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphodiesterase 10A Inhibitor Monotherapy Is Not an Effective Treatment of Acute Schizophrenia.
David P Walling, Anindita Banerjee, Vikas Dawra, Stacey Boyer, Christopher J Schmidt, Nicholas DeMartinis

J Clin Psychopharmacol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia.
Nicholas DeMartinis, Rene N Lopez, Eve H Pickering, Christopher J Schmidt, Lev Gertsik

J Clin Psychopharmacol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel approach to evaluate the pharmacodynamics of a selective dopamine D1/D5 receptor partial agonist (PF-06412562) in patients with stable schizophrenia.
Estibaliz Arce, Rita Balice-Gordon, Sridhar Duvvuri, Melissa Naylor, Zhiyong Xie, Nicholas DeMartinis

J Psychopharmacol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Dopamine D1 Receptor Partial Agonist, PF-06669571, in Subjects with Idiopathic Parkinson's Disease.
Rachel Gurrell, Sridhar Duvvuri, Pengling Sun, Nicholas DeMartinis

Clin Drug Investig· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18F-PF-05270430.
Mika Naganawa, Rikki N Waterhouse, Nabeel Nabulsi, Shu-Fei Lin, David Labaree, Nicholas DeMartinis

J Nucl Med· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New approaches for the treatment of sleep disorders.
Nicholas A DeMartinis, Jayesh Kamath, Andrew Winokur

Adv Pharmacol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychiatric use and utility of divalproex sodium in Connecticut prisons.
Jayesh Kamath, Humberto D Temporini, Susan Quarti, Wanli Zhang, Karen L Pagano, Nicholas Demartinis

Int J Offender Ther Comp Criminol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-blind, placebo-controlled study of the efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder.
Nicholas A DeMartinis, Paul P Yeung, Richard Entsuah, Amy L Manley

J Clin Psychiatry· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of psychiatric medications on sleep and sleep disorders.
Nicholas A DeMartinis, Andrew Winokur

CNS Neurol Disord Drug Targets· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic identification and classification of adverse events in human research.
David I Silverman, Lisanne Cirullo, Nicholas A DeMartinis, Kathryn Damato, Margaret DeMeo

Contemp Clin Trials· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Marathon runner with severe autonomic failure.
Emily M Garland, Satish R Raj, Nicholas Demartinis, David Robertson

Lancet· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia.
Andrew Winokur, Nicholas A DeMartinis, Daniel P McNally, Ellen M Gary, Jennifer L Cormier

J Clin Psychiatry· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study.
Michael R Liebowitz, Nicholas A DeMartinis, Karen Weihs, Peter D Londborg, Ward T Smith

J Clin Psychiatry· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis